Zoetis (ZTS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Zoetis Revenue Highlights

Latest Revenue (Y)

$8.54B

Latest Revenue (Q)

$2.39B

Main Segment (Y)

Total Products and Services

Main Geography (Y)

Total Geographical Area

Zoetis Revenue by Period

Zoetis Revenue by Year

Date	Revenue	Change
2023-12-31	$8.54B	5.74%
2022-12-31	$8.08B	3.91%
2021-12-31	$7.78B	16.49%
2020-12-31	$6.67B	6.63%
2019-12-31	$6.26B	7.47%
2018-12-31	$5.83B	9.76%
2017-12-31	$5.31B	8.57%
2016-12-31	$4.89B	2.58%
2015-12-31	$4.76B	-0.42%
2014-12-31	$4.79B	4.91%
2013-12-31	$4.56B	5.19%
2012-12-31	$4.34B	2.43%
2011-12-31	$4.23B	18.17%
2010-12-31	$3.58B	29.78%
2009-12-31	$2.76B	-

Zoetis generated $8.54B in revenue during NA 2023, up 5.74% compared to the previous quarter, and up 146.68% compared to the same period a year ago.

Zoetis Revenue by Quarter

Date	Revenue	Change
2024-09-30	$2.39B	1.14%
2024-06-30	$2.36B	7.81%
2024-03-31	$2.19B	-1.04%
2023-12-31	$2.21B	2.88%
2023-09-30	$2.15B	-1.33%
2023-06-30	$2.18B	9.00%
2023-03-31	$2.00B	-1.96%
2022-12-31	$2.04B	1.90%
2022-09-30	$2.00B	-2.44%
2022-06-30	$2.05B	3.32%
2022-03-31	$1.99B	0.97%
2021-12-31	$1.97B	-1.16%
2021-09-30	$1.99B	2.16%
2021-06-30	$1.95B	4.12%
2021-03-31	$1.87B	3.54%
2020-12-31	$1.81B	1.18%
2020-09-30	$1.79B	15.37%
2020-06-30	$1.55B	0.91%
2020-03-31	$1.53B	-8.36%
2019-12-31	$1.67B	5.68%
2019-09-30	$1.58B	2.39%
2019-06-30	$1.55B	6.32%
2019-03-31	$1.46B	-6.97%
2018-12-31	$1.56B	5.68%
2018-09-30	$1.48B	4.59%
2018-06-30	$1.42B	3.59%
2018-03-31	$1.37B	-6.44%
2017-12-31	$1.46B	8.39%
2017-10-01	$1.35B	6.15%
2017-07-02	$1.27B	3.09%
2017-04-02	$1.23B	-3.60%
2016-12-31	$1.28B	2.90%
2016-10-02	$1.24B	2.73%
2016-07-03	$1.21B	3.96%
2016-04-03	$1.16B	-8.79%
2015-12-31	$1.27B	4.94%
2015-09-27	$1.21B	3.32%
2015-06-28	$1.18B	6.62%
2015-03-29	$1.10B	-16.52%
2014-12-31	$1.32B	9.09%
2014-09-28	$1.21B	4.49%
2014-06-29	$1.16B	5.56%
2014-03-30	$1.10B	-12.52%
2013-12-31	$1.25B	13.69%
2013-09-29	$1.10B	-0.99%
2013-06-30	$1.11B	2.20%
2013-03-31	$1.09B	-7.31%
2012-12-31	$1.18B	15.41%
2012-09-30	$1.02B	-6.86%
2012-06-30	$1.09B	4.49%
2012-03-31	$1.05B	-7.10%
2011-12-31	$1.13B	7.44%
2011-09-30	$1.05B	-2.33%
2011-06-30	$1.07B	9.26%
2011-03-31	$983.00M	-

Zoetis generated $2.39B in revenue during Q3 2024, up 1.14% compared to the previous quarter, and up 109.54% compared to the same period a year ago.

Zoetis Revenue Breakdown

Zoetis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Other Pharmaceuticals	$1.28B	-	-	-	-
Vaccines	$1.77B	-	-	-	-
Total Products and Services	$8.47B	-	-	-	-
Parasiticides	$1.95B	-	-	-	-
Other Non Pharmaceuticals	$254.00M	-	-	-	-
Medicated Feed Additives	$354.00M	-	-	-	-
Dermatology	$1.43B	-	-	-	-
Contract Manufacturing and Human Health Diagnostics	$78.00M	$86.00M	$82.00M	$83.00M	$85.00M
Anti-infective Products	$1.06B	-	-	-	-
Animal Health Diagnostics	$376.00M	-	-	-	-

Zoetis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Total Products and Services (49.77%), Parasiticides (11.45%), Vaccines (10.41%), Dermatology (8.39%), Other Pharmaceuticals (7.52%), Anti-infective Products (6.21%), Animal Health Diagnostics (2.21%), Medicated Feed Additives (2.08%), Other Non Pharmaceuticals (1.49%), and Contract Manufacturing and Human Health Diagnostics (0.46%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Cattle	$391.00M	$391.00M	$401.00M	$374.00M	$329.00M	$399.00M	$377.00M	$371.00M	$328.00M	$364.00M	$413.00M	$403.00M	$342.00M	$399.00M	$451.00M	-	-	-	-	-
Swine	$131.00M	$127.00M	$139.00M	$129.00M	$133.00M	$142.00M	$138.00M	$129.00M	$144.00M	$154.00M	$155.00M	$153.00M	$161.00M	$190.00M	$167.00M	-	-	-	-	-
Horses	$58.00M	$66.00M	$5.09B	$60.00M	$65.00M	$72.00M	$4.75B	$58.00M	$63.00M	$64.00M	$4.24B	$60.00M	$68.00M	$60.00M	$3.29B	-	-	-	-	-
Poultry	$139.00M	$139.00M	$127.00M	$127.00M	$131.00M	$139.00M	$115.00M	$116.00M	$121.00M	$124.00M	$118.00M	$124.00M	$134.00M	$131.00M	$125.00M	-	-	-	-	-
Dogs and Cats	$1.55B	$1.38B	-	$1.35B	$1.42B	$1.15B	$-3.45B	$1.21B	$1.30B	$1.20B	$-3.06B	$1.14B	$1.16B	$1.02B	$-2.31B	-	-	-	-	-
Fish	$70.00M	$45.00M	$62.00M	$57.00M	$52.00M	$49.00M	$61.00M	$60.00M	$47.00M	$44.00M	$55.00M	$56.00M	$39.00M	$37.00M	$47.00M	-	-	-	-	-
Other Non Pharmaceuticals	-	-	$122.00M	$64.00M	$68.00M	$66.00M	$63.00M	$63.00M	$58.00M	$58.00M	$60.00M	$57.00M	$56.00M	$55.00M	-	-	-	-	-	-
Parasiticides	-	-	$947.00M	$568.00M	$432.00M	$443.00M	$422.00M	$536.00M	$459.00M	$389.00M	$396.00M	$460.00M	$390.00M	$306.00M	-	-	-	-	-	-
Total Products and Services	-	-	$4.32B	$2.16B	$1.98B	$2.01B	$1.98B	$2.03B	$1.97B	$1.94B	$1.97B	$1.93B	$1.85B	$1.78B	-	-	-	-	-	-
Vaccines	-	-	$912.00M	$430.00M	$429.00M	$418.00M	$449.00M	$446.00M	$405.00M	$422.00M	$421.00M	$417.00M	$413.00M	$390.00M	-	-	-	-	-	-
Animal Health Diagnostics	-	-	$187.00M	$96.00M	$93.00M	$85.00M	$83.00M	$87.00M	$98.00M	$91.00M	$95.00M	$99.00M	$89.00M	$89.00M	-	-	-	-	-	-
Anti-infective Products	-	-	$525.00M	$244.00M	$288.00M	$279.00M	$284.00M	$233.00M	$285.00M	$306.00M	$329.00M	$259.00M	$321.00M	$336.00M	-	-	-	-	-	-
Dermatology	-	-	$776.00M	$359.00M	$292.00M	$351.00M	$348.00M	$319.00M	$311.00M	$321.00M	$326.00M	$285.00M	$248.00M	$260.00M	-	-	-	-	-	-
Medicated Feed Additives	-	-	$183.00M	$84.00M	$87.00M	$99.00M	$78.00M	$85.00M	$98.00M	$106.00M	$99.00M	$103.00M	$112.00M	$124.00M	-	-	-	-	-	-
Other Pharmaceuticals	-	-	$358.00M	$313.00M	$315.00M	$294.00M	$272.00M	$252.00M	$265.00M	$254.00M	$249.00M	$243.00M	$248.00M	$226.00M	$224.00M	$208.00M	$192.00M	$197.00M	-	-
Manufactured Product, Other	-	-	-	$29.00M	$26.00M	$29.00M	$19.00M	$32.00M	$28.00M	$19.00M	$19.00M	$31.00M	$23.00M	$22.00M	$16.00M	-	-	-	-	-
Companion Animal	-	-	-	$1.41B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Livestock	-	-	-	$716.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract Manufacturing and Human Health Diagnostics	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$22.00M	$19.00M

Zoetis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Dogs and Cats (66.28%), Cattle (16.71%), Poultry (5.94%), Swine (5.60%), Fish (2.99%), and Horses (2.48%).

Zoetis Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
CANADA	$255.00M	$238.00M	$232.00M	$210.00M	$206.00M
BRAZIL	$393.00M	$330.00M	$312.00M	$258.00M	$293.00M
AUSTRALIA	$323.00M	$289.00M	$259.00M	$207.00M	$196.00M
UNITED STATES	$4.55B	$4.31B	$4.04B	$3.56B	$3.20B
Total Geographical Area	$8.47B	$7.99B	$7.69B	$6.59B	$6.17B
SPAIN	$122.00M	$118.00M	$128.00M	$112.00M	$114.00M
MEXICO	$162.00M	$136.00M	$133.00M	$116.00M	$117.00M
JAPAN	$158.00M	$173.00M	$186.00M	$177.00M	$158.00M
ITALY	$121.00M	$111.00M	$115.00M	$90.00M	$112.00M
GERMANY	$202.00M	$176.00M	$183.00M	$159.00M	$153.00M
FRANCE	$142.00M	$126.00M	$132.00M	$118.00M	$117.00M
CHINA	$320.00M	$382.00M	$357.00M	$266.00M	$200.00M
CHILE	$140.00M	$141.00M	$136.00M	$100.00M	-

Zoetis's latest annual revenue breakdown by geography, as of Dec 23: Total Geographical Area (55.12%), UNITED STATES (29.66%), BRAZIL (2.56%), AUSTRALIA (2.10%), CHINA (2.08%), CANADA (1.66%), GERMANY (1.32%), MEXICO (1.05%), JAPAN (1.03%), FRANCE (0.92%), CHILE (0.91%), SPAIN (0.79%), and ITALY (0.79%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
MEXICO	$171.00M	$44.00M	$43.00M	$42.00M	$38.00M	$39.00M	$35.00M	$33.00M	$33.00M	$35.00M	$35.00M	$31.00M	$34.00M	$33.00M	$32.00M	$26.00M	$26.00M	$32.00M	$30.00M	$29.00M
UNITED KINGDOM	$239.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
AUSTRALIA	$83.00M	$73.00M	$75.00M	$84.00M	$82.00M	$82.00M	$64.00M	$80.00M	$80.00M	$65.00M	$63.00M	$70.00M	$69.00M	$57.00M	$53.00M	$60.00M	$51.00M	$43.00M	$46.00M	$53.00M
United States Segment	$1.41B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
JAPAN	$94.00M	$37.00M	$38.00M	$34.00M	$47.00M	$39.00M	$36.00M	$37.00M	$41.00M	$59.00M	$46.00M	$43.00M	$50.00M	$47.00M	$44.00M	$39.00M	$53.00M	$41.00M	$40.00M	$39.00M
BRAZIL	-	$101.00M	$117.00M	$101.00M	$91.00M	$84.00M	$97.00M	$70.00M	$86.00M	$77.00M	$85.00M	$78.00M	$75.00M	$74.00M	$77.00M	$62.00M	$56.00M	$63.00M	$87.00M	$72.00M
CANADA	-	$61.00M	$72.00M	$63.00M	$70.00M	$50.00M	$66.00M	$56.00M	$67.00M	$49.00M	$63.00M	$56.00M	$67.00M	$46.00M	$66.00M	$50.00M	$54.00M	$40.00M	$64.00M	$47.00M
CHILE	-	$31.00M	$31.00M	$31.00M	$39.00M	$39.00M	$35.00M	$31.00M	$34.00M	$41.00M	$36.00M	$32.00M	$34.00M	$34.00M	$28.00M	$24.00M	$25.00M	-	-	-
CHINA	-	$76.00M	$65.00M	$69.00M	$84.00M	$102.00M	$91.00M	$92.00M	$96.00M	$103.00M	$68.00M	$72.00M	$94.00M	$123.00M	$68.00M	$66.00M	$66.00M	$66.00M	$44.00M	$40.00M
FRANCE	-	$41.00M	$40.00M	$34.00M	$34.00M	$34.00M	$35.00M	$28.00M	$31.00M	$32.00M	$34.00M	$31.00M	$32.00M	$35.00M	$36.00M	$29.00M	$24.00M	$29.00M	$34.00M	$24.00M
SPAIN	-	$32.00M	$28.00M	$30.00M	$31.00M	$33.00M	$21.00M	$29.00M	$35.00M	$33.00M	$31.00M	$33.00M	$33.00M	$31.00M	$29.00M	$31.00M	$24.00M	$28.00M	$28.00M	$29.00M
GERMANY	-	$51.00M	$54.00M	$50.00M	$53.00M	$45.00M	$44.00M	$43.00M	$46.00M	$43.00M	$48.00M	$47.00M	$50.00M	$38.00M	$47.00M	$38.00M	$40.00M	$34.00M	$42.00M	$35.00M
ITALY	-	$28.00M	$34.00M	$26.00M	$35.00M	$26.00M	$25.00M	$24.00M	$32.00M	$30.00M	$28.00M	$30.00M	$32.00M	$25.00M	$27.00M	$28.00M	$14.00M	$21.00M	$30.00M	$26.00M
Total Geographical Area	-	$2.17B	$2.19B	$2.13B	$2.16B	$1.98B	$2.01B	$1.98B	$2.03B	$1.97B	$1.94B	$1.97B	$1.93B	$1.85B	$1.78B	$1.76B	$1.53B	$1.51B	$1.65B	$1.56B
UNITED STATES	-	$1.16B	$1.21B	$1.17B	$1.17B	$1.00B	$1.11B	$1.09B	$1.09B	$1.02B	$1.04B	$1.06B	$1.00B	$933.00M	$952.00M	$996.00M	$823.00M	$786.00M	$861.00M	$844.00M

Zoetis's latest quarterly revenue breakdown by geography, as of Sep 24: United States Segment (70.64%), UNITED KINGDOM (11.96%), MEXICO (8.55%), JAPAN (4.70%), and AUSTRALIA (4.15%).

Zoetis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TAK	Takeda Pharmaceutical Company	$4.26T	$1.05T
TEVA	Teva Pharmaceutical Industries	$15.85B	$4.33B
VTRS	Viatris	$15.43B	$3.74B
HLN	Haleon	$11.30B	$2.92B
BHC	Bausch Health Companies	$8.76B	$2.51B
ZTS	Zoetis	$8.54B	$2.39B
ELAN	Elanco Animal Health	$4.42B	$1.18B
CTLT	Catalent	$4.38B	$1.02B
NBIX	Neurocrine Biosciences	$1.89B	$622.10M
EBS	Emergent BioSolutions	$1.05B	$254.70M
AMPH	Amphastar Pharmaceuticals	$593.24M	$188.82M
ITCI	Intra-Cellular Therapies	$462.18M	$175.38M
ASRT	Assertio	$152.07M	$29.20M
ALVO	Alvotech	$91.43M	$12.43M

ZTS Revenue FAQ

What is Zoetis’s yearly revenue?

Zoetis's yearly revenue for 2023 was $8.54B, representing an increase of 5.74% compared to 2022. The company's yearly revenue for 2022 was $8.08B, representing an increase of 3.91% compared to 2021. ZTS's yearly revenue for 2021 was $7.78B, representing an increase of 16.49% compared to 2020.

What is Zoetis’s quarterly revenue?

Zoetis's quarterly revenue for Q3 2024 was $2.39B, a 1.14% increase from the previous quarter (Q2 2024), and a 11.02% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.36B, a 7.81% increase from the previous quarter (Q1 2024), and a 8.30% increase year-over-year (Q2 2023). ZTS's quarterly revenue for Q1 2024 was $2.19B, a -1.04% decrease from the previous quarter (Q4 2023), and a 9.50% increase year-over-year (Q1 2023).

What is Zoetis’s revenue growth rate?

Zoetis's revenue growth rate for the last 3 years (2021-2023) was 9.88%, and for the last 5 years (2019-2023) was 36.49%.

What are Zoetis’s revenue streams?

Zoetis's revenue streams in c 23 are Other Pharmaceuticals, Vaccines, Total Products and Services, Parasiticides, Other Non Pharmaceuticals, Medicated Feed Additives, Dermatology, Contract Manufacturing and Human Health Diagnostics, Anti-infective Products, and Animal Health Diagnostics. Other Pharmaceuticals generated $1.28B in revenue, accounting 7.52% of the company's total revenue Vaccines generated $1.77B in revenue, accounting 10.41% of the company's total revenue Total Products and Services generated $8.47B in revenue, accounting 49.77% of the company's total revenue Parasiticides generated $1.95B in revenue, accounting 11.45% of the company's total revenue Other Non Pharmaceuticals generated $254M in revenue, accounting 1.49% of the company's total revenue Medicated Feed Additives generated $354M in revenue, accounting 2.08% of the company's total revenue Dermatology generated $1.43B in revenue, accounting 8.39% of the company's total revenue Contract Manufacturing and Human Health Diagnostics generated $78M in revenue, accounting 0.46% of the company's total revenue, down -9.30% year-over-year. Anti-infective Products generated $1.06B in revenue, accounting 6.21% of the company's total revenue Animal Health Diagnostics generated $376M in revenue, accounting 2.21% of the company's total revenue

What is Zoetis’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Zoetis was Total Products and Services. This segment made a revenue of $8.47B, representing 49.77% of the company's total revenue.